Biopharma CEO Investor Forum
The Biopharma Sustainability Roundtable (BSRT) and CECP’s CEO Investor Forum invite you to join nine leading leading biopharma CEOs for the first-ever sector-specific Biopharma CEO Investor Forum, June 7-8, 2021. CEOs from Catalent, GlaxoSmithKline, Incyte, Merck & Co., Moderna, Pfizer, Sanofi, Takeda, and UCB will share their Long-Term Plans for sustainable value creation with leading institutional investors and the wider stakeholder community.
Register here for complimentary access.
Participating CEOs are using the Biopharma Investor Communications Guidance, the product of over two years of dialogue between biopharma companies and institutional investors, to inform and tailor their long-term presentations.
This special two-day event will also feature contributions from Alex Gorsky, CEO, Johnson & Johnson; Andrew Edgecliff-Johnson, Financial Times; Dr. Sanjay Gupta, Chief Medical Correspondent, CNN; Susanne Stormer, Member of the Sustainability Accounting Standards Board (SASB); Luke Timmerman, Editor of the Timmerman Report; Meg Tirrell, Senior Health and Science Reporter, CNBC; and Tensie Whelan, Director, NYU Stern Center for Sustainable Business.
You are welcome to share this event with colleagues, and we will provide updates as additional speakers are added to the lineup.
Hope to see you at this exciting first-ever event!
Registration for the Biopharma CEO Investor Forum is complimentary. This is a Reg FD investor event and is open to the public.